A rare case of interstitial pneumonitis after tandem high-dose melphalan conditioning and autologous stem cell transplantation in multiple myeloma

Eur J Haematol. 2004 Aug;73(2):143-6. doi: 10.1111/j.1600-0609.2004.00276.x.

Abstract

A 57-yr-old woman with multiple myeloma received an autologous tandem transplant at a 4-month interval. She was conditioned twice with 225 mg/m2 melphalan. After the second transplant, interstitial pneumonitis (IP) ensued. The clinical course was life threatening and mechanical ventilation was required for 32 d. All attempts to identify an infectious agent failed. A presumptive diagnosis of idiopathic IP, possibly related to melphalan toxicity, was made. High-dose methylprednisolone administration led to rapid and durable improvement. Melphalan was employed for conditioning in the tandem setting with an interval of only 3-4 months between two courses or a dose elevation to 225 instead of 200 mg/m2, may have induced IP which responded favorably to methylprednisolone.

Publication types

  • Case Reports

MeSH terms

  • Anthracyclines / adverse effects
  • Female
  • Heart Diseases / chemically induced
  • Heart Diseases / etiology
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Lung Diseases, Interstitial / chemically induced*
  • Lung Diseases, Interstitial / etiology
  • Melphalan / adverse effects*
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Multiple Myeloma / complications*
  • Multiple Myeloma / therapy*
  • Transplantation Conditioning / adverse effects*
  • Transplantation Conditioning / methods
  • Transplantation, Autologous
  • Treatment Outcome

Substances

  • Anthracyclines
  • Melphalan
  • Methylprednisolone